Ciltacabtagene Autoleucel Vs Standard of Care in Patients with Functional High-Risk Multiple Myeloma: CARTITUDE-4 Subgroup Analysis.
Clinical Lymphoma Myeloma and Leukemia(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined